USPTO serial 79218814
RIBOMAB
Reviewed by CopyMark Law Group
Reg. 5510495Status 709
- Filing date
- Status date
- Registration date
- Jul 10, 2018
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RIBOMAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and veterinary preparations, of all kinds, namely, pharmaceuticals and veterinary preparations for treating cancerous diseases, infections, autoimmune disorders and metabolic disorders; diagnostic preparations for the detection of cancerous diseases, infections, autoimmune disorders and metabolic disorders | SECTION 71 - CANCELLED | — |
| 040 | Treatment of materials and material conversion, namely, custom manufacture of chemicals and biochemical substances; custom manufacture of chemicals and biochemical substances; custom manufacture of therapeutic preparations for the treatment of cancerous diseases, infections, autoimmune disorders and metabolic disorders | SECTION 71 - CANCELLED | — |
| 042 | Scientific research for medical and veterinary purposes, in particular in respect of approaches for treating cancerous diseases, infections, autoimmune disorders and metabolic disorders | SECTION 71 - CANCELLED | — |
| 044 | Medical and veterinary services in connection with the treatment of cancerous diseases, infections, autoimmune disorders and metabolic disorders | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioNTech RNA Pharmaceuticals GmbH
- Other trademarks owned by BioNTech RNA Pharmaceuticals GmbH
- Other trademarks owned by BioNTech RNA Pharmaceuticals GmbH
- Other trademarks owned by BioNTech SE
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RIBOMAB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 27, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 26, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 26, 2026 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Mar 12, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 11, 2026 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Mar 11, 2026 | INPC | INVALIDATION PROCESSED | — |
| Sep 24, 2025 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 24, 2025 | C71T | CANCELLED SECTION 71 | — |
| Apr 15, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 31, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Nov 9, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 22, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 22, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 10, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 10, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 24, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 4, 2018 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 20, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 13, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 9, 2018 | ALIE | ASSIGNED TO LIE | — |
| Feb 26, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 27, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 8, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 8, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 19, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 14, 2017 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Dec 5, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 4, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 27, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 23, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 19, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |